Yüklüyor......

Kinase inhibitor profiling reveals unexpected opportunities to inhibit disease-associated mutant kinases

Small-molecule kinase inhibitors have typically been designed to inhibit wild-type kinases rather than the mutant forms that frequently arise in diseases such as cancer. Mutations can have serious clinical implications by increasing kinase catalytic activity or conferring therapeutic resistance. To...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cell Rep
Asıl Yazarlar: Duong-Ly, Krisna C., Devarajan, Karthik, Liang, Shuguang, Horiuchi, Kurumi Y., Wang, Yuren, Ma, Haiching, Peterson, Jeffrey R.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2016
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4740242/
https://ncbi.nlm.nih.gov/pubmed/26776524
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.celrep.2015.12.080
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!